ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1961

Chemokine-like Receptor 1 (CMKLR1) is Expressed on Synoviocytes and Proinflammatory Monocytes in Arthritis and is Predominantly Regulated By β arrestin 2 and G Protein Coupled Receptor Kinase (GRK) 6

D. Stephen Serafin1, Maria F. Sassano2, Daniel Mattox1, Roman Timoshchenko1, Matthew J. Billard1, David P. Siderovski3, Bryan Roth4 and Teresa K. Tarrant5, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Pharmacology, Dept. of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Physiology and Pharmacology, West Virginia University School of Medicine, Morgantown, WV, 4Dept. of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Medicine/Rheumatology, Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Arthritis, Chemokine Receptors, monocytes and synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Chemokine-like receptor 1 (CMKLR1) is a G protein-coupled receptor (GPCR) expressed by inflammatory monocytes and up-regulated in fibroblast-like synoviocytes (FLSs), both of which are pathogenic in osteoarthritis (OA) and rheumatoid arthritis (RA).  Its cognate ligand, chemerin, is a chemoattractant for invading inflammatory cells and is present in the synovial lining of arthritis patients. In OA and RA, chemerin/CMKLR1 signaling contributes to disease pathogenesis via recruitment of inflammatory leukocytes and stimulates breakdown of cartilage matrix by metalloproteases.

CMKLR1, like most GPCRs, is desensitized by recruitment of G protein receptor kinases (GRKs) and β-arrestins.  Due to the significant role of chemerin/CMKLR1 interaction in human inflammatory arthritis, we examined the mechanism of CMKLR1 regulation by G protein receptor kinases (GRK) 2, 3, and 6 and β-arrestin-2.

Methods

De-identified, healthy, OA, and RA human FLSs were cultured for measurement of relative gene expression by qRT-PCR of CMKLR1, GRK2, GRK3 and GRK6 as compared to housekeeping gene IDUA (ΔCt).

A modified Tango assay was used to measure β-arrestin-2 recruitment to CMKLR1. HTLA cells were over-expressed with CMKLR1 and GRK2, GRK3, or GRK6 via calcium phosphate precipitation and stimulated with increasing concentrations of chemerin.  After 24 hours, luminescence was measured on a Promega Glomax Multi+ Detection System.

Peritoneal activated monocytes/macrophages from C57Bl/6 wildtype (WT) and transgenic mice deficient in GRK2, GRK3, GRK6, or β-arrestin-2 (-/-) were studied ex vivo for CMKLR1 receptor internalization and migration. Calcein-labeled monocyte migration to media alone, SDF-1, or chemerin was examined using the FalconTM HTS FluoroBlok 96-Multiwell Insert System (3 µm pore-size) and a Fluoroskan Ascent Microplate Fluorometer. To measure CMKLR1 internalization, receptor surface expression was measured by flow cytometry at 30 sec, 1 min, 5 min and 10 min post-stimulation with chemerin and mean fluorescence intensity (MFI) normalized relative to 0 min on F4/80 positive cells.

Results

Relative gene expression of CMKLR1 is increased in both OA and RA FLS samples compared to normal controls. In addition, RA FLS show increased GRK2, -3, and -6 relative gene expression compared to controls. β-arrestin-2 recruitment to ligand-activated CMKLR1 is preferentially mediated by GRK6 as compared to GRK2 and -3. Additionally, GRK6-/- and β-arrestin-2 -/- murine peritoneal macrophages have enhanced chemotaxis to chemerin, as well as significantly decreased receptor internalization after ligand stimulation when compared to controls.

Conclusion

Chemerin/CMKLR1 signaling has an important role in the pathogenesis of OA and RA through the activation of cells within the joint, as well as recruiting proinflammatory monocytes to sites of inflammation. Chemerin-induced migration of proinflammatory monocytes and CMKLR1 receptor internalization is predominantly regulated by GRK6 phosphorylation and β-arrestin-2 recruitment.


Disclosure:

D. S. Serafin,
None;

M. F. Sassano,
None;

D. Mattox,
None;

R. Timoshchenko,
None;

M. J. Billard,
None;

D. P. Siderovski,
None;

B. Roth,
None;

T. K. Tarrant,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chemokine-like-receptor-1-cmklr1-is-expressed-on-synoviocytes-and-proinflammatory-monocytes-in-arthritis-and-is-predominantly-regulated-by-%ce%b2-arrestin-2-and-g-protein-coupled-rece/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology